Showing news articles based on category Low T Institute.
The safety of testosterone therapy with myocardial infarction (heart attack) patients has been a concern in the medical community. Some experts worry that testosterone therapy could be a catalyst for a heart attack at an earlier age. However, the research indicates that testosterone therapy does not have a negative effect. In fact, after analyzing more […]
Because of fluctuations of serum testosterone levels, some professional associations (and thus insurance companies) have dictated a second morning sample is necessary to verify a low testosterone diagnosis. Low T Center believes that if the first sample is below a particular threshold, a second sample is not warranted. After analyzing samples from 249 patients in […]
The treatment of hypogonadism is based on guidelines that define a lower limit of serum testosterone. However, because physicians and insurance companies have varying definitions of those levels, treatment coverage can be impacted. Low T Center studied patients to determine hormone levels and proposed another classification that can open the door for more patients to […]
Practitioners of testosterone replacement therapy (TRT) are becoming more aware of the need to monitor patients to determine if they are experiencing any health issues that could affect the effectiveness of treatment. Low T Center advocates for patient intake, questioning, and blood work to learn about symptoms and medications that could influence patient health during testosterone […]